Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126361721 | 12636172 | 1 | I | 20160527 | 20160809 | 20160809 | PER | GXBR2016US001978 | SANDOZ | 0.00 | M | Y | 83.90000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126361721 | 12636172 | 1 | PS | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Topical | UNK DF, UNK | 85691 | OINTMENT | |||||||||
| 126361721 | 12636172 | 2 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 126361721 | 12636172 | 3 | C | ATENOLOL. | ATENOLOL | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 126361721 | 12636172 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 126361721 | 12636172 | 5 | C | QUINAPRIL. | QUINAPRIL | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 126361721 | 12636172 | 6 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK DF, UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126361721 | 12636172 | 1 | Rash |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126361721 | 12636172 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |